콘텐츠로 건너뛰기
Merck
  • Gabapentin, Pregabalin and Vigabatrin Quantification in Human Serum by GC-MS After Hexyl Chloroformate Derivatization.

Gabapentin, Pregabalin and Vigabatrin Quantification in Human Serum by GC-MS After Hexyl Chloroformate Derivatization.

Journal of analytical toxicology (2016-09-04)
Tomáš Hložek, Miroslava Bursová, Pavel Coufal, Radomír Čabala
초록

A simple, sensitive and robust method for simultaneous determination of antiepileptic drugs (gabapentin, pregabalin and vigabatrin) in human serum using GC-MS was developed and validated for clinical toxicology purposes. This method employs an emerging class of derivatization agents - alkyl chloroformates allowing the efficient and rapid derivatization of both the amino and carboxylic groups of the tested antiepileptic drugs within seconds. The derivatization protocol was optimized using the Design of Experiment statistical methodology, and the entire sample preparation requires less than 5 min. Linear calibration curves were obtained in the concentration range from 0.5 to 50.0 mg/L, with adequate accuracy (97.9-109.3%) and precision (<12.1%). The method was successfully applied to quantification of selected γ-aminobutyric acid analogs in the serum of patients in both therapeutic and toxic concentration ranges.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
3-(4-Chlorophenyl)propionic acid, 97%
Sigma-Aldrich
Hexyl chloroformate, 97%
Sigma-Aldrich
Butyl chloroformate, 98%